Lucida Medical

Cambridge, United Kingdom · Founded 2019 · Privately Held (backing)

Developer of an artificial intelligence-based healthcare technology designed to assist clinicians in detecting and diagnosing cancer. Lucida Medical is based in Cambridge, United Kingdom and was founded in 2019. Its last reported valuation was $44.7 million in Mar 2026. It has raised $23.6 million.

Last reported valuation
$44.7M
Oct 2026
Priced at
—
Total raised
$23.6M
Last round
—

Who backs Lucida Medical?

18 investors
InvestorType
Innovate UKOther
Creative Destruction LabOther
The FSE GroupVenture capital
Cambridge Enterprise VenturesVenture capital
XTX Ventures—
Empirical VenturesVenture capital
IW CapitalGrowth equity
BlackCap Equity Management—
Conduit Connect—
Macmillan Cancer Support—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Lucida Medical investors

18 investors are on record for Lucida Medical, including Innovate UK, Creative Destruction Lab, The FSE Group and Cambridge Enterprise Ventures.

Free account
More of Lucida Medical with a free account
  • ·The complete investor list: 18 names
  • ·Watch Lucida Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like Lucida Medical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View